Integra LifeSciences Inc. (IART): Market Value

Integra LifeSciences (IART) business relies on the defensive nature of the neurosurgery segment, where the demand for consumables remains stable regardless of GDP growth rates. Integra LifeSciences (IART) maintains leadership in tissue regeneration, offering benchmark solutions for intracranial pressure monitoring. This price chart with a market capitalization of 1.13 confirms the resilience of hospital demand and the success of new implant lines.

IART (Integra LifeSciences Holdings Corporation) Market Value history from 07/04/2022 to 11/11/2026

Financial and market metric breakdowns for Integra LifeSciences Inc. (IART)

- current price and projected stock value:

Stock Price Integra LifeSciences Holdings Corporation|IART - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value Integra LifeSciences Inc.|IART - Value Adjusted for Debt and Cash

- book value of equity indicators:

Accounting Value per Share Integra LifeSciences|IART - Total Net Assets|Market Value to Book Value Ratio integralife.com|IART - Company Total Asset Base

- debt and solvency information:

- net income and valuation multiples indicators:

IART - Net Profit|Expected Profit Integra LifeSciences|IART - Price to Earnings Ratio|Forward P/E Multiple Integra|IART - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Integra LifeSciences Inc.|IART - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Integra LifeSciences|IART - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth integralife.com|IART - Earnings per share growth this year|Expected earnings per share growth for next year Integra LifeSciences

Initial company analysis:Integra LifeSciences Holdings Corporation IART

Original product of Integra LifeSciences Inc.

Integra LifeSciences' high technological competencies in medical equipment allow the market to assess the business recovery potential following production modernization and quality audits. By analyzing the company's total market capitalization, calculated as the product of the current share price and the total number of outstanding shares, an investor determines the degree of asset discounting relative to the risks of a strategic pivot and the pace of correcting regulatory deficiencies.

Competitors of Integra LifeSciences (IART)